(Q37044726)

17 August 2017

title

Sacral neuromodulation: cost considerations and clinical benefits (English)

1 reference

17 August 2017

Sherif R Aboseif

1

1 reference

17 August 2017

Dennis H Kim

2

1 reference

17 August 2017

Jocelyn M Rieder

3

1 reference

17 August 2017

Eugene Y Rhee

4

1 reference

17 August 2017

Shawn A Menefee

5

1 reference

17 August 2017

Julie R Kaswick

6

1 reference

17 August 2017

Michael H Ree

7

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

70

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

1069-73; discussion 1073-4

1 reference

Prevalence and burden of overactive bladder in the United States

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

Estimated economic costs of overactive bladder in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

SACRAL NERVE STIMULATION FOR TREATMENT OF REFRACTORY URINARY URGE INCONTINENCE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

Urinary retention in women: its causes and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

Sacral neuromodulation in functional urinary retention: an effective way to restore voiding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

New Sacral Neuromodulation Lead for Percutaneous Implantation Using Local Anesthesia: Description and First Experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

New percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

Improvement in depression and health-related quality of life after sacral nerve stimulation therapy for treatment of voiding dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.07.073

10.1016/J.UROLOGY.2007.07.073

7 January 2021

Identifiers

DOI

1 reference

17 August 2017

1 reference